Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2.5Revenue $M0.8Net Margin (%)-714.0Z-Score-24.5
Enterprise Value $M3.2EPS $-0.4Operating Margin %-696.9F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-786.8Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsY
Price/Sales5.05-y EBITDA Growth Rate %-23.1Current Ratio0.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-127.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M50.7ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with SNWV

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

SNWV is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SNWV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chiarelli JosephCEO 2014-03-17Buy80,000$0.5-90view
Richardson Kevin A IIDirector, 10% Owner 2014-03-17Buy100,000$0.5-90view
Richardson Kevin A IIDirector, 10% Owner 2013-10-09Buy35,312$0.6-91.67view
Chiarelli JosephCEO 2013-10-09Buy41,667$0.6-91.67view
Jenkins Barry J.CFO 2013-09-19Buy13,500$0.74-93.24view
Cashman Christopher M10% Owner 2013-08-13Sell33,500$0.77-93.51view
Cashman Christopher M10% Owner 2013-06-11Sell34,800$0.8-93.75view
Cashman Christopher M10% Owner 2013-06-06Sell46,100$0.89-94.38view
Cashman Christopher M10% Owner 2013-05-29Sell2,827$0.84-94.05view
Cashman Christopher M10% Owner 2013-05-22Sell73,461$0.96-94.79view

Press Releases about SNWV :

    Quarterly/Annual Reports about SNWV:

    News about SNWV:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    SANUWAVE Health Signs Memoranda of Understanding With Dasman Diabetes Institute and Kuwait Life... Dec 02 2014
    SANUWAVE Enrolls 130th Patient in Its dermaPACE Clinical Trial Treating Diabetic Foot Ulcers Dec 01 2014
    SANUWAVE HEALTH, INC. Financials Nov 22 2014
    SNWV: Expect DMC Recommendation in Q1 Nov 17 2014
    10-Q for SANUWAVE Health, Inc. Nov 14 2014
    SANUWAVE HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... Nov 14 2014
    SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update Nov 12 2014
    SANUWAVE HEALTH, INC. Files SEC form 10-Q, Quarterly Report Nov 12 2014
    SANUWAVE Health to Hold Third Quarter 2014 Financial Results Conference Call on Thursday, November... Nov 06 2014
    Presentation Schedule Now Available for RedChip's October 15-16 Global Online CEO Conference Oct 06 2014
    SNWV: DMC Recommendation Causes 4+ Month Delay Sep 10 2014
    SNWV: DMC Evaluation Expected In September Aug 12 2014
    SANUWAVE HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... Aug 08 2014
    SANUWAVE HEALTH, INC. Files SEC form 10-Q, Quarterly Report Aug 06 2014
    SANUWAVE HEALTH, INC. Files SEC form 8-K, Change in Directors or Principal Officers Aug 05 2014
    SANUWAVE HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation... May 15 2014
    SANUWAVE's (SNWV) Q1 2014 Results - Earnings Call Transcript May 14 2014
    SNWV: We Remain Very Positive on Chances for Trial Success May 14 2014
    SANUWAVE HEALTH, INC. Files SEC form 10-Q, Quarterly Report May 13 2014
    SANUWAVE HEALTH, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in... Apr 21 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK